Vigilant Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$86K Buy
195
+100
+105% +$46.1K 0.01% 230
2023
Q1
$44K Sell
95
-23
-19% -$10.9K ﹤0.01% 281
2022
Q4
$60K Sell
118
-56
-32% -$28.4K 0.01% 253
2022
Q3
$79K Hold
174
0.01% 242
2022
Q2
$84K Buy
174
+79
+83% +$39.1K 0.01% 228
2022
Q1
$46K Hold
95
﹤0.01% 306
2021
Q4
$44K Sell
95
-17
-15% -$7.15K ﹤0.01% 332
2021
Q3
$42K Buy
112
+44
+65% +$16.7K ﹤0.01% 282
2021
Q2
$26K Buy
68
+10
+17% +$3.82K ﹤0.01% 324
2021
Q1
$21K Hold
58
﹤0.01% 295
2020
Q4
$19K Hold
58
﹤0.01% 278
2020
Q3
$16K Buy
+58
New +$15.6K ﹤0.01% 289
2020
Q1
Sell
-40
Closed -$12K 350
2019
Q4
$12K Hold
40
﹤0.01% 413
2019
Q3
$10K Hold
40
﹤0.01% 344
2019
Q2
$11K Buy
+40
New +$10.9K ﹤0.01% 344
2019
Q1
Sell
-63
Closed -$17K 425
2018
Q4
$17K Buy
+63
New +$17.3K ﹤0.01% 343
2015
Q1
Sell
-45
Closed -$6K 272
2014
Q4
$6K Buy
45
+32
+246% +$3.95K ﹤0.01% 272
2014
Q3
$2K Buy
+13
New +$1.49K ﹤0.01% 281

Other funds holding ELV

Vigilant Capital Management's ELV Position: Q2 2023 in Review

Vigilant Capital Management increased its Elevance Health (ELV) stake by 105% in Q2 2023, buying an estimated $46.1K and bringing the position to 195 shares worth $86K. The position accounts for 0.01% of the portfolio, ranked #230.

Vigilant Capital Management first reported a position in ELV in Q3 2014 and has held it in 18 quarters since. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Vigilant Capital Management held 195 shares of Elevance Health worth $86K as of Q2 2023.
  • Vigilant Capital Management bought 100 Elevance Health shares in Q2 2023, an estimated $46.1K.
  • Elevance Health made up 0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #230 holding.
  • Vigilant Capital Management first reported a position in Elevance Health in Q3 2014 and has held it in 18 quarters since.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.